The role of apolipoproteins in cardiovascular disease has been well investigated, but their
participation in cancer has only been explored in a few published studies which showed a …

Apolipoprotein D (ApoD) is lipocalin able to bind hydrophobic ligands. The APOD gene is
upregulated in a number of pathologies, including Alzheimer's disease, Parkinson's disease …

Apolipoprotein D (apoD) is a 29-kDa glycoprotein that is primarily associated with high
density lipoproteins in human plasma. It is an atypical apolipoprotein and, based on its …

The development and use of molecular-based therapy for breast cancer and other human
malignancies will require a detailed molecular genetic analysis of patient tissues. The recent …

Gene expression patterns in ductal carcinoma in situ (DCIS), and in invasive, and metastatic
breast tumors were determined using serial analysis of gene expression (SAGE). We used …

BREAST cancer is the most common malignancy among females in North America. Statistics
show that in the United States alone, about 200,000 new cases are diagnosed every year …

Purpose: Proteomic analysis of breast nipple aspirate fluid (NAF) holds promise as a
noninvasive method to identify markers of breast cancer. The objectives of the study were …

There has been increasing attention on immune-oncology for its impressive clinical benefits
in many different malignancies. However, due to molecular and genetic heterogeneity of …

Apolipoprotein D is a chordate gene early originated in the Lipocalin protein family. Among
other features, regulation of its expression in a wide variety of disease conditions in humans …

Lipocalins are mainly extracellular carriers of lipophilic molecules, though exceptions with
properties like prostaglandin synthesis and protease inhibition are observed for specific …